Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novartis -- Ignore unavailable to you. Want to Upgrade?

To: TheSlowLane who wrote (88)	11/3/1997 8:33:00 AM
From: Chuck. Edwards	Read Replies (1) \| Respond to of 296

Just a brief note on Chiron, in response to an earlier post. Chiron has a reputation for good science, coupled with an utter failure to bring it to market in the form of usable drugs. There is enough dissatisfaction with the CEO that he might ultimately be forced out, though Novartis would probably have the ultimate say on such a move. Good investing!

To: TheSlowLane who wrote (88)	11/3/1997 8:45:00 AM
From: Tom Wilkes	Read Replies (1) \| Respond to of 296

Yeah, well, I grew up around trains. Novartis is a fast one, but its a long moving target. I'll catch it just right. As for IPOs, I never bought an IPO anyway. Is this one secret or private or strictly limited or something, or is it like any other, requiring only a willing broker? Anyway, if the company (name?) is really worth its salt, it will continue to go up and up, post-IPO, as we all buy in! If not, who wants it? But, good luck. I wish you success. Tom (Jeez, you'd think a guy would have a little pity for a poor schoolteacher).